ASO Author Reflections: Fathoming the Dilemma of the Optimal Time to Surgery for Patients with Resectable Esophageal Cancer After Neoadjuvant Chemoradiotherapy
机构：[1]School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.四川省人民医院[2]Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.四川省人民医院四川省肿瘤医院
第一作者机构：[1]School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.[2]Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
通讯作者：
推荐引用方式(GB/T 7714)：
Li Jingqiu,Wang Qifeng.ASO Author Reflections: Fathoming the Dilemma of the Optimal Time to Surgery for Patients with Resectable Esophageal Cancer After Neoadjuvant Chemoradiotherapy[J].Annals Of Surgical Oncology.2024,31(6):3852-3853.doi:10.1245/s10434-024-14989-4.
APA：
Li Jingqiu&Wang Qifeng.(2024).ASO Author Reflections: Fathoming the Dilemma of the Optimal Time to Surgery for Patients with Resectable Esophageal Cancer After Neoadjuvant Chemoradiotherapy.Annals Of Surgical Oncology,31,(6)
MLA：
Li Jingqiu,et al."ASO Author Reflections: Fathoming the Dilemma of the Optimal Time to Surgery for Patients with Resectable Esophageal Cancer After Neoadjuvant Chemoradiotherapy".Annals Of Surgical Oncology 31..6(2024):3852-3853
医学